Cardinal Eyeing Further Acquisitions In China
This article was originally published in PharmAsia News
Cardinal Health's recent acquisition of Zuellig Pharma China (Yong Yu in Chinese) likely will not be the last China-based distributor the U.S. wholesaler will pick up, according to company CFO Jeff Henderson
You may also be interested in...
Alliance Boots Doubles Down In China With 12% Stake Of Nanjing Pharma
As MNCs increase stakes in China’s pharmaceutical distribution market, the highly segmented nature of the industry will remain a challenge for market penetration, analysts say.
Riding Consolidation Wave, Cardinal Health Looks To New Business Models In China
The second largest U.S. pharmaceutical distributor sees China as a growth engine and platform for innovation.